Critical issues you need to address now
How will clinical laboratory payments be affected by the Protecting Access to Medicare Act (PAMA) for 2019 and beyond? Which lab/pathology coding and billing issues are being targeted, as of June 2018, by Recovery Audit Contractors (RACs)? Which common charging errors are putting lab revenues at risk?
Recent trends make it more important than ever to get answers to these and other urgent questions. And nobody has a better handle on the latest critical issues than Robin Miller Zweifel, BS, MT (ASCP) – she's been our go-to laboratory expert for nearly two decades. Plan to join us for this midyear laboratory state of the union webcast, as Robin dissects and interprets a variety of current topics relevant to defending and preserving laboratory revenues.
What's on the agenda:
- Which laboratory services are at the highest risk for payment reductions under PAMA
- Guidance with avoiding costly errors in the selection of CPT® codes for molecular pathology and genetic sequencing procedures
- How to correctly interpret and apply AMA, CMS and commercial payer coding guidelines specific to drug-of-abuse testing, molecular pathology and automated test procedures in hematology, chemistry and more
- Understanding the potential impact of the new issues approved for RACs, including payment for laboratory add-on codes when the primary code is missing or denied
- Identifying documentation vulnerabilities that place your laboratory at risk for denied payments
- Real-life scenarios that reinforce the impact of revenue-related pitfalls in the lab setting
- Time permitting, answers to attendee questions
Who Should Attend:
Laboratory director or manager, lab information services (LIS) staff, revenue integrity staff, outpatient billing staff and compliance staff.
CPT® is a registered trademark of the American Medical Association.